Cargando…
A novel cascade machine learning pipeline for Alzheimer’s disease identification and prediction
INTRODUCTION: Alzheimer’s disease (AD) is a progressive and irreversible brain degenerative disorder early. Among all diagnostic strategies, hippocampal atrophy is considered a promising diagnostic method. In order to proactively detect patients with early Alzheimer’s disease, we built an Alzheimer’...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884698/ https://www.ncbi.nlm.nih.gov/pubmed/36726800 http://dx.doi.org/10.3389/fnagi.2022.1073909 |
_version_ | 1784879775306743808 |
---|---|
author | Zhou, Kun Piao, Sirong Liu, Xiao Luo, Xiao Chen, Hongyi Xiang, Rui Geng, Daoying |
author_facet | Zhou, Kun Piao, Sirong Liu, Xiao Luo, Xiao Chen, Hongyi Xiang, Rui Geng, Daoying |
author_sort | Zhou, Kun |
collection | PubMed |
description | INTRODUCTION: Alzheimer’s disease (AD) is a progressive and irreversible brain degenerative disorder early. Among all diagnostic strategies, hippocampal atrophy is considered a promising diagnostic method. In order to proactively detect patients with early Alzheimer’s disease, we built an Alzheimer’s segmentation and classification (AL-SCF) pipeline based on machine learning. METHODS: In our study, we collected coronal T1 weighted images that include 187 patients with AD and 230 normal controls (NCs). Our pipeline began with the segmentation of the hippocampus by using a modified U2-net. Subsequently, we extracted 851 radiomics features and selected 37 features most relevant to AD by the Hierarchical clustering method and Least Absolute Shrinkage and Selection Operator (LASSO) algorithm. At last, four classifiers were implemented to distinguish AD from NCs, and the performance of the models was evaluated by accuracy, specificity, sensitivity, and area under the curve. RESULTS: Our proposed pipeline showed excellent discriminative performance of classification with AD vs NC in the training set (AUC=0.97, 95% CI: (0.96-0.98)). The model was also verified in the validation set with Dice=0.93 for segmentation and accuracy=0.95 for classification. DISCUSSION: The AL-SCF pipeline can automate the process from segmentation to classification, which may assist doctors with AD diagnosis and develop individualized medical plans for AD in clinical practice. |
format | Online Article Text |
id | pubmed-9884698 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98846982023-01-31 A novel cascade machine learning pipeline for Alzheimer’s disease identification and prediction Zhou, Kun Piao, Sirong Liu, Xiao Luo, Xiao Chen, Hongyi Xiang, Rui Geng, Daoying Front Aging Neurosci Aging Neuroscience INTRODUCTION: Alzheimer’s disease (AD) is a progressive and irreversible brain degenerative disorder early. Among all diagnostic strategies, hippocampal atrophy is considered a promising diagnostic method. In order to proactively detect patients with early Alzheimer’s disease, we built an Alzheimer’s segmentation and classification (AL-SCF) pipeline based on machine learning. METHODS: In our study, we collected coronal T1 weighted images that include 187 patients with AD and 230 normal controls (NCs). Our pipeline began with the segmentation of the hippocampus by using a modified U2-net. Subsequently, we extracted 851 radiomics features and selected 37 features most relevant to AD by the Hierarchical clustering method and Least Absolute Shrinkage and Selection Operator (LASSO) algorithm. At last, four classifiers were implemented to distinguish AD from NCs, and the performance of the models was evaluated by accuracy, specificity, sensitivity, and area under the curve. RESULTS: Our proposed pipeline showed excellent discriminative performance of classification with AD vs NC in the training set (AUC=0.97, 95% CI: (0.96-0.98)). The model was also verified in the validation set with Dice=0.93 for segmentation and accuracy=0.95 for classification. DISCUSSION: The AL-SCF pipeline can automate the process from segmentation to classification, which may assist doctors with AD diagnosis and develop individualized medical plans for AD in clinical practice. Frontiers Media S.A. 2023-01-16 /pmc/articles/PMC9884698/ /pubmed/36726800 http://dx.doi.org/10.3389/fnagi.2022.1073909 Text en Copyright © 2023 Zhou, Piao, Liu, Luo, Chen, Xiang and Geng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Aging Neuroscience Zhou, Kun Piao, Sirong Liu, Xiao Luo, Xiao Chen, Hongyi Xiang, Rui Geng, Daoying A novel cascade machine learning pipeline for Alzheimer’s disease identification and prediction |
title | A novel cascade machine learning pipeline for Alzheimer’s disease identification and prediction |
title_full | A novel cascade machine learning pipeline for Alzheimer’s disease identification and prediction |
title_fullStr | A novel cascade machine learning pipeline for Alzheimer’s disease identification and prediction |
title_full_unstemmed | A novel cascade machine learning pipeline for Alzheimer’s disease identification and prediction |
title_short | A novel cascade machine learning pipeline for Alzheimer’s disease identification and prediction |
title_sort | novel cascade machine learning pipeline for alzheimer’s disease identification and prediction |
topic | Aging Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884698/ https://www.ncbi.nlm.nih.gov/pubmed/36726800 http://dx.doi.org/10.3389/fnagi.2022.1073909 |
work_keys_str_mv | AT zhoukun anovelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction AT piaosirong anovelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction AT liuxiao anovelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction AT luoxiao anovelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction AT chenhongyi anovelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction AT xiangrui anovelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction AT gengdaoying anovelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction AT zhoukun novelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction AT piaosirong novelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction AT liuxiao novelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction AT luoxiao novelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction AT chenhongyi novelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction AT xiangrui novelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction AT gengdaoying novelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction |